Fed Dissenters Voice Opposition to Rate Cut Hints in Latest Policy Statement JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India What It Means Charlotte Motor Speedway Becomes Memorial for Kyle Busch as RCR Retires No 8 Car for Son Brexton Chinas Coal Strategy Powering the Next Phase of Energy Dominance Indias Consumption Shift Experiences and Premium Goods Drive Market Evolution Equinix Stock Outlook Wall Street Sentiment Reflects Cautious Optimism on Data Center Demand FrancoNevada Q1 2026 Earnings EPS Beats Estimates by 137 Shares Edge Higher FirstSun Capital Bancorp Q1 2026 Earnings EPS Misses Estimates Stock Slips LXP Industrial Trust Q1 2026 Earnings Miss on EPS Shares Edge Higher Teekay Tankers Ltd Q1 2026 Earnings EPS Surpasses Estimates by 106 Amidst Robust Tanker Markets ABUS Q1 2026 Earnings Wider Loss Than Expected as Biotech Reports No Revenue Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings EPS Beat Narrowed Net Loss No Revenue Reported Lumentum Holdings LITE Holds Near 902 as Support and Resistance Levels Come into Focus Manulife Financial MFC Edges Lower Amid Consolidation Near Key Levels Origin Bancorp OBK Holds Near Support Amid Modest Decline Galata Acquisition Corp II Warrant LATAW Surges 30 as Price Nears Key Resistance MDxHealth MDXH Slides 625 as Cancer Diagnostics Stock Tests Key Support Level Trinity Capital TRIN Q1 2026 Earnings EPS Beats Estimates Stock Dips on Broader Market Headwinds PGY Q1 2026 Earnings Massive EPS Beat Highlights Operational Leverage but Stock Slips Minerva Neurosciences Q1 2026 Earnings EPS Misses Street Estimates Stock Gains on Pipeline Optimism Quanterix QTRX Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Surge FUBO Q1 2026 Earnings Strong EPS Beat Drives Narrower Loss Yet Stock Declines Stellantis and Jaguar Land Rover Collaborate on US Vehicle Development Dating Startups Target Trust New Apps Aim to Eliminate Fake Profiles in Online Dating CTOR Q1 2026 Earnings Deep Losses and Negative Surprise as Company Remains PreRevenue Barinthus Biotherapeutics BRNS Edges Higher Small Uptick in LowPriced Stock